LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cristina Ciampelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Sassari, via Francesco Muroni 25, 07100 Sassari, Italy. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Drosophila melanogaster, Drosophila Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DM 737/2021, Bando competitivo Fondazione di Sardegna 2017-Iaccarino, Fondazione di Sardegna Annualità 2022–2023 Progetti di ricerca di base dipartimentali.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a fatal neurodegenerative disease for which there are no still effective treatments able to stop or slow down neurodegeneration. To date, pathological mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been identified as the major genetic cause of PD, although the molecular mechanism responsible for the loss of dopaminergic neurons is still cryptic. In this review, we explore the contribution of Drosophila models to the elucidation of LRRK2 function in different cellular pathways in either neurons or glial cells. Importantly, recent studies have shown that LRRK2 is highly expressed in immunocompetent cells, including astrocytes and microglia in the brain, compared to neuronal expression. LRRK2 mutations are also strongly associated with the development of inflammatory diseases and the production of inflammatory molecules. Using Drosophila models, this paper shows that a genetic reduction of the inflammatory response protects flies from the neurodegeneration induced by LRRK2 pathological mutant expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Sassari, via Francesco Muroni 25, 07100 Sassari, Italy.
- Department Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
- Department of Agricultural Sciences, University of Sassari, 07100 Sassari, Italy.
ORCID-Profile: Cristina Ciampelli, Grazia Galleri, Paolo Mereu, Monica Pirastru, Roberto Bernardoni, Diego Albani, Claudia Crosio, Ciro Iaccarino
Förderung
- DM 737/2021
- Bando competitivo Fondazione di Sardegna 2017-Iaccarino
- Fondazione di Sardegna Annualità 2022–2023 Progetti di ricerca di base dipartimentali
- Fondo di Ateneo per la ricerca 2020
- Bando interno per la ricerca collaborativa tra Ateneo di Sassari e Ateneo di Cagliari-Formato
- Bando interno per la ricerca collaborativa tra Ateneo di Sassari e Ateneo di Cagliari
- Risorse 2022–2023-Formato
- Progetti di ricerca interdisciplinare
Zitieren
APA
Ciampelli, C., Galleri, G., Galioto, M., Mereu, P., Pirastru, M., Bernardoni, R., Albani, D., Crosio, C., & Iaccarino, C. (2025). LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052093
Vancouver
Ciampelli C, Galleri G, Galioto M, Mereu P, Pirastru M, Bernardoni R, et al. LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052093
BibTeX
@article{Ciampelli2025,
author = {Ciampelli, Cristina and Galleri, Grazia and Galioto, Manuela and Mereu, Paolo and Pirastru, Monica and Bernardoni, Roberto and Albani, Diego and Crosio, Claudia and Iaccarino, Ciro},
title = {LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052093}
}
EUVIMED